Recovery of synaptic distribution was also evident in recent studies after treatment of synucleinopathy models with recombinant CTSD (rHsCTSD) as well as GCase activators [16, 106], both restoring SNCA pathology while normalizing Synapsin-1 expression and localization. Here, CTSD is linked to synucleinopathy.